Skip to main content

Coastlands Capital LP's Form 4 filing

Pasithea Therapeutics Corp.KTTA · filed Nov 17, 2026

Accession no.
0001104659-26-129251
Filed
Nov 17, 2026, 8:42 PM ET
Trade date
Nov 13-17, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market purchases total $805.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Coastlands Capital LPCIK 000206853010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2026Common StockPPurchaseAcquired+209,431$0.4956+$103,7944,044,466Indirect
Nov 16, 2026Common StockPPurchaseAcquired+583,083$0.4989+$290,900.114,627,549Indirect
Nov 17, 2026Common StockPPurchaseAcquired+875,000$0.47+$411,2505,502,549Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)